A study in the journal Pediatrics evaluated the efficacy of primary BNT162b2, mRNA-1273, and heterologous mRNA Covid-19 vaccines in preventing hospitalization amongst adolescents in Sweden, Norway, Finland, and Denmark. It found that vaccine effectiveness against hospitalization ranged from 73% to 86% at six months, with the protection remaining consistent up to a year, including during the Omicron wave.
‘Amber alert’ as NHS in Plymouth makes urgent plea for people with certain blood type
The NHS has issued an urgent call for O type blood donors, following increased demand after the recent cyber attack. The attack led to reduced
